$MIRM

$85.56 +$2.29 (2.75%) Close

$MIRM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$MIRM Management Team

Mr. Doug Sheehy

Chief Legal officer

Age -

Compensation -

Sex Male

Mr. Peter Radovich

President

Chief Operating Officer

Age 47

Compensation $3.338M USD

Sex Male

Mr. Christopher Peetz

Chief Executive Officer

Co-Founder

Director

Age 46

Compensation $6.599M USD

Sex Male

Mr. Eric Bjerkholt

Chief Financial Officer

Age 65

Compensation $2.006M USD

Sex Male

Dr. Pamela Vig

Chief Scientific Officer

Head of Research

Age 53

Compensation $1.507M USD

Sex Female

Dr. Joanne Quan

Chief Medical Officer

Age 61

Compensation $3.589M USD

Sex Female

Ms. Lara Longpre

Chief Development Officer

Age 54

Compensation $1.507M USD

Sex Female

Mr. Andrew Mckibben

Investor Relations

Age -

Compensation -

Sex Male

Mr. Michael Grey

Independent Chairman of the Board

Age 72

Compensation $408.5K USD

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Doug Sheehy Chief Legal officer	-	-	Male
Mr. Peter Radovich President Chief Operating Officer	47	$3.338M USD	Male
Mr. Christopher Peetz Chief Executive Officer Co-Founder Director	46	$6.599M USD	Male
Mr. Eric Bjerkholt Chief Financial Officer	65	$2.006M USD	Male
Dr. Pamela Vig Chief Scientific Officer Head of Research	53	$1.507M USD	Female
Dr. Joanne Quan Chief Medical Officer	61	$3.589M USD	Female
Ms. Lara Longpre Chief Development Officer	54	$1.507M USD	Female
Mr. Andrew Mckibben Investor Relations	-	-	Male
Mr. Michael Grey Independent Chairman of the Board	72	$408.5K USD	Male

Board of Directors

From the proxy statement filed Apr 23, 2026

Directors

serving now

Independent

8 of 8

stated in the proxy; 1 not stated

Average tenure

5.7 years

from year joined

CEO also chairs the board

Michael Grey

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Lon Cardon	60	2022 4 years	Independent	None stated	None stated	Not stated
William Fairey	62	2021 5 years	Independent	Audit	Ascendis Pharma, Inc.	$421,718
Timothy Walbert	59	2023 3 years	Independent	None stated	Century Therapeutics, Inc., BioMarin Pharmaceutical Inc., Sagimet Biosciences Inc.	$414,843
Laurent Fischer	62	2019 7 years	Independent	None stated	AtaiBeckley Inc.	$429,843
Patrick Heron	55	2018 8 years	Independent	Compensation	Arcutis Biotherapeutics, Inc., MBX Biosciences, Inc.	$409,843
Saira Ramasastry	50	2022 4 years	Independent	Audit	Vir Biotechnology, Inc., Glenmark Pharmaceuticals, Ltd., Day One Biopharmaceuticals, Inc.	Not stated
Laura Brege	68	2019 7 years	Independent	None stated	Acadia Pharmaceuticals Inc., Pacira BioSciences, Inc., Edgewise Therapeutics Inc.	$440,468
Michael Grey Board chair	73	2020 6 years	Independent	None stated	OnKure Therapeutics, Inc., Spruce Biosciences, Inc.	$459,843
Christopher Peetz CEO	47	2019 7 years	Not stated	None stated	None stated	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$MIRM Management Team

Mr. Doug Sheehy

Mr. Peter Radovich

Mr. Christopher Peetz

Mr. Eric Bjerkholt

Dr. Pamela Vig

Dr. Joanne Quan

Ms. Lara Longpre

Mr. Andrew Mckibben

Mr. Michael Grey

Board of Directors

Related-party transactions

No related-party transactions disclosed